scholarly journals Relationships among Serum Testosterone Levels, Body Fat and Muscle Mass Distribution in Women with Polycystic Ovary Syndrome.

2001 ◽  
Vol 48 (6) ◽  
pp. 685-689 ◽  
Author(s):  
TSUTOMU DOUCHI ◽  
NOBUYUKI YOSHIMITSU ◽  
YUKIHIRO NAGATA
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Muscle Mass ◽  
Mass Distribution ◽  
Body Fat ◽  
Polycystic Ovary ◽  
Serum Testosterone ◽  
Ovary Syndrome ◽  
Testosterone Levels

Suppression of Serum Insulin by Diazoxide Reduces Serum Testosterone Levels in Obese Women with Polycystic Ovary Syndrome*

1989 ◽  
Vol 68 (6) ◽  
pp. 1027-1032 ◽  
Author(s):  
JOHN E. NESTLER ◽  
CORNELIUS O. BARLASCINI ◽  
DENNIS W. MATT ◽  
KENNETH A. STEINGOLD ◽  
STEPHEN R. PLYMATE ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Serum Insulin ◽  
Serum Testosterone ◽  
Obese Women ◽  
Ovary Syndrome ◽  
Testosterone Levels

Serum testosterone levels in the polycystic ovary syndrome

1974 ◽  
Vol 120 (3) ◽  
pp. 385-389 ◽  
Author(s):  
William E. Easterling ◽  
Luther M. Talbert ◽  
H.D. Potter
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Serum Testosterone ◽  
Ovary Syndrome ◽  
Testosterone Levels

Serum Testosterone Levels Decrease in Middle Age in Women With the Polycystic Ovary Syndrome

2000 ◽  
Vol 55 (9) ◽  
pp. 560-561
Author(s):  
Stephen J. Winters ◽  
Evelyn Talbott ◽  
David S. Guzick ◽  
Jeanne Zborowski ◽  
Kathleen P. McHugh
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Middle Age ◽  
Polycystic Ovary ◽  
Serum Testosterone ◽  
Ovary Syndrome ◽  
Testosterone Levels

Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome

2000 ◽  
Vol 73 (4) ◽  
pp. 724-729 ◽  
Author(s):  
Stephen J Winters ◽  
Evelyn Talbott ◽  
David S Guzick ◽  
Jeanne Zborowski ◽  
Kathleen P McHugh
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Middle Age ◽  
Polycystic Ovary ◽  
Serum Testosterone ◽  
Ovary Syndrome ◽  
Testosterone Levels

Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome

2018 ◽  
Vol 82 ◽  
pp. 32-37 ◽  
Author(s):  
Aleksandra Konieczna ◽  
Dominik Rachoń ◽  
Katarzyna Owczarek ◽  
Paweł Kubica ◽  
Agnieszka Kowalewska ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Bisphenol A ◽  
Polycystic Ovary ◽  
Serum Testosterone ◽  
Ovary Syndrome ◽  
Testosterone Levels

scholarly journals Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels

2011 ◽  
Vol 165 (1) ◽  
pp. 63-68 ◽  
Author(s):  
Ekaterini Koiou ◽  
Konstantinos Tziomalos ◽  
Ilias Katsikis ◽  
Emmanuil Kalaitzakis ◽  
Eleni A Kandaraki ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Serum Testosterone ◽  
Normal Weight ◽  
Healthy Population ◽  
Ovary Syndrome ◽  
Total Study Population ◽  
Testosterone Levels ◽  
Group I ◽  
Group Ii

ObjectiveWomen with polycystic ovary syndrome (PCOS) appear to have higher cardiovascular risk than healthy population. Patients diagnosed with PCOS according to the 1990 criteria have a more adverse metabolic profile than those diagnosed with the 2003 criteria. Platelet-derived microparticles (PMPs) appear to contribute to atherosclerosis but have not been assessed in PCOS. The aim of this study was to determine plasma PMPs in PCOS patients.DesignA cross-sectional study.MethodsWe assessed plasma PMPs in 76 normal weight women with PCOS (39 belonging to the phenotypes 1 and 2 (group I) and 37 belonging to the phenotypes 3 and 4 (group II)) and 21 healthy normal weight women.ResultsMarkers of obesity and insulin resistance did not differ between women with PCOS and controls. Serum testosterone levels and the free androgen index (FAI) were higher in group I than in group II and controls (P<0.001 for all comparisons) but did not differ between the latter two groups. Plasma PMPs were higher in group I than in controls (P=0.018) but did not differ between group II and controls or between groups I and II. In the total study population (n=97), plasma PMPs correlated with serum testosterone levels (r=0.207, P=0.042) and the FAI (r=0.207, P=0.042).ConclusionsPlasma PMPs are elevated in women with phenotypes 1 and 2 of PCOS compared with healthy controls, but not in women with phenotypes 3 and 4. Hyperandrogenemia, which is more pronounced in phenotypes 1 and 2, appears to be implicated in the increase in plasma PMPs.

Sign in / Sign up

Export Citation Format

Share Document